August 12, 2024
Valitor to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

July 19, 2023
Valitor Expands Leadership Team with Appointment of Omkar Joshi, Ph.D. as Vice President of CMC

April 24, 2023
Valitor Presents Preclinical Data on its Long-acting Anti-VEGF Biologic in Development for Durable Treatment of Wet AMD at the Association for Research in Vision and Ophthalmology Annual Meeting

April 10, 2023
Valitor to Present on the Potential for its Multivalent Polymer Technology to Expand the Therapeutic Index of Oncology Agents at the 2023 American Association for Cancer Research Annual Meeting

March 23, 2023
Valitor to Present at the Association for Research in Vision and Ophthalmology Annual Meeting

December 01, 2022
Valitor Announces Presentation on Novel Anti-VEGF Antibody Conjugate and Multivalent Polymer Technology Platform at Upcoming Ophthalmology Innovation Source (OIS) Summit - Preclinical data support twice-yearly dosing in wet AMD -

October 05, 2022
Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer